サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413854

再生医療における人工知能市場：技術、提供、用途、エンドユーザー別-2024-2030年の世界予測

Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
再生医療における人工知能市場：技術、提供、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

再生医療における人工知能市場規模は2023年に5,963万米ドルと推計され、2024年には7,238万米ドルに達すると予測され、CAGR 22.05%で2030年には2億4,063万米ドルに達する見込みです。

再生医療における人工知能の世界市場

主な市場の統計
基準年[2023］ 5,963万米ドル
予測年[2024] 7,238万米ドル
予測年 [2030] 2億4,063万米ドル
CAGR（%） 22.05%
再生医療における人工知能 Market-IMG1

人工知能（AI）は、人体内で損傷したり失われたりした組織や臓器を修復、置換、再生するための学際的アプローチであるため、再生医療における重要性が増しています。AI技術は、研究を加速し、患者ケアを強化し、治療結果を改善するために、再生医療の様々な側面に適用されています。再生医療市場におけるAIは、機械学習アルゴリズム、深層学習システム、自然言語処理ツール、ロボット工学などのAI技術を幹細胞療法、組織工学、免疫療法、遺伝子編集技術に統合することを包含しています。官民両部門における研究開発活動への資金提供の増加は、AIなどの先端技術の採用を加速させています。加えて、がんや心血管疾患などの慢性疾患の有病率が上昇していることから、AIを活用した再生医療が提供する画期的なソリューションによってのみ対応可能な革新的な治療アプローチに対する需要が高まっており、市場の成長がさらに高まっています。しかし、AIアルゴリズムのトレーニングに使用される患者情報の機密性のためにデータプライバシーに関する懸念が生じ、AIシステムによって使用される複雑なアルゴリズムが市場導入の妨げとなっています。個別化治療の登場と次世代シークエンシング（NGS）技術の進歩により、高度な分析手法を必要とする膨大な量のデータが生成されており、これが再生医療におけるAIの応用に新たな機会をもたらしています。

地域別の洞察

南北アメリカは、大規模な投資やパートナーシップ、市場におけるイノベーションに継続的に注力している主要市場プレイヤーの存在により、再生医療における人工知能市場において重要な地位を占めています。さらに、政府主導により、臓器再生と修復のための新しい治療アプローチを開発するためにAI技術を統合することに重点を置く様々な分野の研究者が集まっています。欧州連合（EU）では、Horizon 2020などの資金提供プログラムが、AIベースの再生医療プロジェクトを推進するために多額のリソースを割り当てています。政府は、機械学習アルゴリズムを使用して人間のあらゆる細胞タイプをマッピングするプロジェクトをいくつか立ち上げており、この地域の市場導入にさらに拍車をかけています。APAC地域は、政府の多額の投資を背景に、AIベースの再生医療を急速に進めています。大手企業は、再生療法を含む医療問題にAI技術を適用する専門のヘルスケア部門を設立しています。政府はまた、ヘルスケアやバイオテクノロジーなどの産業を支援するため、再生医療向けのAI技術を開発する戦略的イニシアチブを打ち出しており、同地域の市場導入をさらに促進しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、再生医療における人工知能市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、再生医療における人工知能市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-再生医療における人工知能市場の市場規模および予測は？

2-再生医療における人工知能市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-再生医療における人工知能市場における技術動向と規制の枠組みは？

4-再生医療における人工知能市場における主要ベンダーの市場シェアは？

5-再生医療における人工知能市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患や希少疾患の罹患率の増加
      • 精密医薬品と幹細胞治療に対する消費者の嗜好の高まり
      • ヘルスケア分野におけるAIの導入に対する政府の支援的取り組み
    • 抑制要因
      • 再生医療向けのAIベースのソリューションに関連する高コスト
    • 機会
      • 創薬と開発を改善するための技術の進歩
      • AI導入のための資金と投資の増加
    • 課題
      • データプライバシーに関する懸念と、熟練した専門家の確保が限られている
  • 市場セグメンテーション分析
    • テクノロジー：重要な生物学的構造を正確かつ効率的に検出するためにコンピュータービジョンテクノロジーを大幅に採用
    • オファリング：ハードウェアは、再生医療におけるAIアプリケーションに必要な計算能力を提供します。
    • 応用例：創薬応用におけるAL技術の活用の可能性
    • エンドユーザー：製薬会社とバイオテクノロジー会社は、AIを活用して創薬を加速することに重点を置いています
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 再生医療における人工知能市場：技術別

  • コンピュータビジョン
  • コンテキストアウェアコンピューティング
  • 機械学習
  • 自然言語処理

第7章 再生医療における人工知能市場：提供別

  • ハードウェア
    • メモリ
    • 通信網
    • プロセッサー
  • サービス
  • ソフトウェア

第8章 再生医療における人工知能市場：用途別

  • サイバーセキュリティ
  • 創薬
  • 不正行為の検出
  • ヘルスケア支援ロボット
  • 医用画像および診断
  • 患者データとリスク分析
  • 精密医療

第9章 再生医療における人工知能市場：エンドユーザー別

  • ヘルスケア支払者
  • 病院と医療提供者
  • 製薬およびバイオテクノロジー企業

第10章 南北アメリカの再生医療における人工知能市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の再生医療における人工知能市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの再生医療における人工知能市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Cognetivity Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Intel Corporation
    • Medtronic PLC
    • Merck KGaA
    • Microsoft Corporation
    • NANO-X IMAGING LTD.
    • Novo Nordisk A/S
    • NVIDIA Corporation
    • Sanofi SA
    • Tempus Labs, Inc.
    • Wipro Limited
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEMORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY CYBERSECURITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY FRAUD DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY MEDICAL IMAGING & DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PATIENT DATA & RISK ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 240. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. ARTIFICIAL INTELLIGENCE IN REGENERATIVE MEDICINE MARKET LICENSE & PRICING
目次
Product Code: MRR-A6768A62EE04

[196 Pages Report] The Artificial Intelligence in Regenerative Medicine Market size was estimated at USD 59.63 million in 2023 and expected to reach USD 72.38 million in 2024, at a CAGR 22.05% to reach USD 240.63 million by 2030.

Global Artificial Intelligence in Regenerative Medicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 59.63 million
Estimated Year [2024] USD 72.38 million
Forecast Year [2030] USD 240.63 million
CAGR (%) 22.05%
Artificial Intelligence in Regenerative Medicine Market - IMG1

Artificial intelligence (AI) is increasingly important in regenerative medicine as it is a multidisciplinary approach to repairing, replacing, or regenerating damaged or lost tissues and organs within the human body. AI technologies are applied to various aspects of regenerative medicine to accelerate research, enhance patient care, and improve treatment outcomes. The AI in the regenerative medicine market encompasses integrating AI technologies such as machine learning algorithms, deep learning systems, natural language processing tools, and robotics with stem cell therapy, tissue engineering, immunotherapies, and gene editing techniques. Increased funding for research & development activities in both public and private sectors has accelerated the adoption of advanced technologies such as AI. Additionally, the rising prevalence of chronic conditions such as cancer and cardiovascular diseases has increased demand for innovative treatment approaches that can only be met through groundbreaking solutions provided by AI-enabled regenerative medicine, further increasing market growth. However, data privacy concerns arise due to the sensitive nature of patient information used for training AI algorithms, and the complex algorithms used by AI systems hamper market adoption. The advent of personalized therapy and advances in next-generation sequencing (NGS) technologies have generated vast amounts of data requiring sophisticated analysis methods; this poses yet another opportunity for AI's application within the regenerative medicine landscape.

Regional Insights

The Americas hold a significant landscape in the artificial intelligence in regenerative medicine market owing to significant investments and partnerships and the presence of key market players continuously focusing on innovations in the market. Additionally, the government initiative brings together researchers from various fields who focus on integrating AI technologies to develop novel therapeutic approaches for organ regeneration and repair. In the European Union, funding programs such as Horizon 2020 have allocated substantial resources to advance AI-based regenerative medicine projects. The government has launched several projects to map every human cell type using machine learning algorithms, further fueling the region's market adoption. APAC region is rapidly advancing in AI-based regenerative medicine, backed by significant government investments. Leading companies have established dedicated healthcare units that apply AI technologies to medical issues, including regenerative therapies. The government has also launched strategic initiatives to develop AI technologies for regenerative medicine to support industries such as healthcare and biotechnology, further fueling market adoption in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Cognetivity Ltd., F. Hoffmann-La Roche Ltd., Intel Corporation, Medtronic PLC, Merck KGaA, Microsoft Corporation, NANO-X IMAGING LTD., Novo Nordisk A/S, NVIDIA Corporation, Sanofi SA, Tempus Labs, Inc., and Wipro Limited.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
  • Offering
    • Hardware
      • Memory
      • Network
      • Processor
    • Services
    • Software
  • Application
    • Cybersecurity
    • Drug Discovery
    • Fraud Detection
    • Healthcare Assistance Robots
    • Medical Imaging & Diagnostics
    • Patient Data & Risk Analysis
    • Precision Medicine
  • End-User
    • Healthcare Payers
    • Hospitals & Providers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Regenerative Medicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic and rare diseases
      • 5.1.1.2. Growing consumer preference for precision medicines and stem cell therapies
      • 5.1.1.3. Supportive government initiatives for deployment of AI in healthcare sector
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with AI-based solutions for regenerative medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technologies for improved drug discovery and development
      • 5.1.3.2. Rising funding and investments for deployment of AI
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy coupled with limited availability of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Significant adoption of computer vision technology for accurate and efficient detection of key biological structures
    • 5.2.2. Offering: Hardware provides the necessary computational power in AI applications in regenerative medicine
    • 5.2.3. Application: Potential utilization of AL technology in drug discovery applications
    • 5.2.4. End-User: Pharmaceutical and biotechnology companies focus on leveraging AI to accelerate drug discovery
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Regenerative Medicine Market, by Technology

  • 6.1. Introduction
  • 6.2. Computer Vision
  • 6.3. Context-Aware Computing
  • 6.4. Machine Learning
  • 6.5. Natural Language Processing

7. Artificial Intelligence in Regenerative Medicine Market, by Offering

  • 7.1. Introduction
  • 7.2. Hardware
    • 7.3.1. Memory
    • 7.3.2. Network
    • 7.3.3. Processor
  • 7.3. Services
  • 7.4. Software

8. Artificial Intelligence in Regenerative Medicine Market, by Application

  • 8.1. Introduction
  • 8.2. Cybersecurity
  • 8.3. Drug Discovery
  • 8.4. Fraud Detection
  • 8.5. Healthcare Assistance Robots
  • 8.6. Medical Imaging & Diagnostics
  • 8.7. Patient Data & Risk Analysis
  • 8.8. Precision Medicine

9. Artificial Intelligence in Regenerative Medicine Market, by End-User

  • 9.1. Introduction
  • 9.2. Healthcare Payers
  • 9.3. Hospitals & Providers
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Artificial Intelligence in Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Regenerative Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Regenerative Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Axolotl Biologix and Carmell Therapeutics Enter Merger Deal
    • 13.3.2. Agreement, Collaboration, & Partnership
      • 13.3.2.1. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
      • 13.3.2.2. Wipro and Pandorum Partner to Accelerate Regenerative Medicine with Artificial Intelligence

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Cognetivity Ltd.
    • 14.1.2. F. Hoffmann-La Roche Ltd.
    • 14.1.3. Intel Corporation
    • 14.1.4. Medtronic PLC
    • 14.1.5. Merck KGaA
    • 14.1.6. Microsoft Corporation
    • 14.1.7. NANO-X IMAGING LTD.
    • 14.1.8. Novo Nordisk A/S
    • 14.1.9. NVIDIA Corporation
    • 14.1.10. Sanofi SA
    • 14.1.11. Tempus Labs, Inc.
    • 14.1.12. Wipro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing